T1	Participants 48 100	patients presenting with acute myocardial infarction
T2	Participants 195 243	Primary percutaneous coronary intervention (PCI)
T3	Participants 659 784	Patients with ischemic chest pain with duration < or =12 hours and no contraindication for thrombolytic therapy were included
T4	Participants 794 919	Between October 1993 and August 1995, 58 patients were randomly assigned to streptokinase (SK) and 54 patients to primary PCI
T5	Participants 922 1009	aseline clinical characteristics and infarct location were well balanced in both groups
